• Home
  • Contact

CSIR-CFTRI to provide testing equipment for COVID-19 detection

Biotech Today — April 6, 2020 in News 11 Likes 224 Views Share TwitterTweet on Twitter FacebookShare on Facebook Google+Google+ PinterestPinterest

Mysuru-based CSIR-CFTRI has joined hands with the district administration by making available testing equipment for COVID-19 detection.

The post CSIR-CFTRI to provide testing equipment for COVID-19 detection appeared first on BioTech Times.

Source

CFTRI Covid-19 News testing equipment

About the Author: Biotech Today

You might like

Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability

2 hours ago 0 Likes 2

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

2 hours ago 0 Likes 2

Pfizer and Valneva to start phase 3 Lyme disease vaccine study

4 hours ago 0 Likes 2

Positive trial results for schizophrenia drug, KarTX, from PureTech’s founded entity, Karuna Therapeutics

21 hours ago 0 Likes 2

Building a healthtech industry in Europe to serve patients

23 hours ago 0 Likes 2

Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca

1 day ago 0 Likes 2
[cm_ad_changer group_id="3"]

Recent Posts

  • Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents
  • Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability
  • Pfizer and Valneva to start phase 3 Lyme disease vaccine study
  • Positive trial results for schizophrenia drug, KarTX, from PureTech’s founded entity, Karuna Therapeutics
  • Building a healthtech industry in Europe to serve patients
  • Epigenic Therapeutics raises $20M for gene editing technology
  • Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca
  • HUTCHMED drug in colorectal cancer trial meets primary endpoint
  • Dallas College gets $8.8M grant to grow biotech workforce in North Texas
  • Allogenic immune cell therapies to be developed as three groups join forces
[cm_ad_changer group_id="4"]
[cm_ad_changer group_id="5"]
© 2020 biotechTODAY - Designed by Legendary Group